ORR,OS,PFS

Clinical trials for ORR,OS,PFS explained in plain language.

Never miss a new study

Get alerted when new ORR,OS,PFS trials appear

Sign up with your email to follow new studies for ORR,OS,PFS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New cocktail of drugs shows promise for tough bile duct cancer

Disease control Not yet recruiting

This phase 2 trial tests a combination of sintilimab (an immunotherapy), bevacizumab (a targeted therapy), and chemotherapy (albumin-bound paclitaxel plus gemcitabine) as a first treatment for people with advanced bile duct cancer that cannot be surgically removed. The study aims…

Matched conditions: ORR,OS,PFS

Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated Jun 27, 2026 08:10 UTC

ORR,OS,PFS

Get alerted when new ORR,OS,PFS trials appear

New cocktail of drugs shows promise for tough bile duct cancer